Illumina Inc 2022 Investor Day Transcript
Good morning. Please welcome to the stage Vice President of Investor Relations, Sally Schwartz.
So we just had a great week convening innovators across the genomics industry at the Illumina Genomics Forum. And during our Investor Day event today, multiple speakers will touch on how much our customers appreciated it and the groundbreaking technology that we launched at the event. Thank you for joining us here today, both everyone here in the room and everyone joining us virtually on the webcast. My name is Salli Schwartz, and I'm Illumina's Vice President of Investor Relations. Prior to joining Illumina, I spent the past almost dozen years, leading investor relations companies -- Investor Relations teams at various companies. And before that, I held a variety of corporate and financial advisory roles.
Before we get started, I need to provide a few cautionary notes. So on this slide behind me are really important disclaimers for our business. They include a statement reflecting the current
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |